• Home
  •  / Privo Technologies

Privo Technologies

    OverviewSuggest Edit

    Privo Technologies is a company that develops nanotechnology-based drug delivery platform. It is capable of local and systemic delivery of a constant, controlled therapeutic dose through the mucosa. The company focuses on oral cancer followed by intraopertaive chemotherapy as well as on human papillomavirus (HPV)-caused cancers.
    TypePrivate
    Founded2009
    HQPeabody, MA, USMap
    Websiteprivotechnologies.com

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Jan 2022)8(-20%)
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Privo Technologies

    Manijeh Goldberg

    Manijeh Goldberg

    Chief Executive Officer, Founder and Chairman of the Board
    James MacKay

    James MacKay

    Chief Advisor and Independent Board Member
    Nishant Agrawal

    Nishant Agrawal

    Chief Medical Advisor
    Show more

    Privo Technologies Office Locations

    Privo Technologies has an office in Peabody
    Peabody, MA, US (HQ)
    200 Corporate Pl #6b
    Show all (1)

    Privo Technologies Financials and Metrics

    Summary Metrics

    Founding Date

    		2009

    Privo Technologies Online and Social Media Presence

    Privo Technologies's Trends

    Embed Graph

    Privo Technologies News and Updates

    October 22, 2021

    Privo Technologies, Inc. Announces Positive Results From Phase 1/2 Clinical Trial for PRV111 in Head and Neck Squamous Cell Carcinoma

    August 23, 2021

    Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant

    August 19, 2021

    Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition

    PEABODY, Mass., Aug. 19, 2021 /PRNewswire/ -- Privo Technologies, Inc. ("Privo"), a biopharmaceutical company focused on breakthrough localized treatments for tough to treat mucosal cancers, announced today that Privo and its CEO, Manijeh Goldberg, Ph.D., have been selected as the winner...
    June 03, 2021

    Privo Technologies, Inc. to Present Phase II Data for PRV111 in Head and Neck Squamous Cell Carcinoma at the Upcoming 2021 ASCO Annual Meeting

    June 30, 2020

    Privo Technologies Announces the Appointment of Dr. James Mackay to Its Board of Directors

    Privo Technologies (Privo), a Leader in the Field of Novel, Nanotechnology-Based Localized Oncology Treatments, is Pleased to Announce the Appointment of Dr. James Mackay to Its Board of Directors.

     Privo Technologies Frequently Asked Questions

    • When was Privo Technologies founded?

      Privo Technologies was founded in 2009.

    • Who are Privo Technologies key executives?

      Privo Technologies's key executives are Manijeh Goldberg, James MacKay and Nishant Agrawal.

    • How many employees does Privo Technologies have?

      Privo Technologies has 8 employees.

    • Who are Privo Technologies competitors?

      Competitors of Privo Technologies include Nanospectra Biosciences, Dare Bioscience and Co-D Therapeutics.

    • Where is Privo Technologies headquarters?

      Privo Technologies headquarters is located at 200 Corporate Pl #6b, Peabody.

    • Where are Privo Technologies offices?

      Privo Technologies has an office in Peabody.

    • How many offices does Privo Technologies have?

      Privo Technologies has 1 office.